Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Cancer Engineering Training Program

Award Number: T32CA254875
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 08/19/2021
PERIOD OF PERFORMANCE END DATE: 08/31/2031

Group Awards By:

View Award Description

Cancer Engineering Training Program - PROJECT ABSTRACT The central mission of the T32 “Cancer Engineering Training Program” (CETP) will be to train the next generation of basic and translational scientists to develop and apply cutting-edge engineering-based approaches to address fundamental and translational challenges in cancer biology, diagnosis, and treatment. This overall goal will be achieved under the auspices of five key themes: (1) Genetic and Tissue Engineering, (2) Imaging and Theranostics, (3) Integrative Computational Biology and Oncology, (4) Immuno-engineering, and (5) Nanotechnology and Biomaterials. This T32 CETP research portfolio is situated at the intersection of various disciplines—from basic science including chemistry and physics, structural biology, drug development, cell biology, and developmental biology to cancer biology, invasion and metastasis, and applied disciplines, including pharmacology, nanotechnology, radiochemistry, engineering, and medicine—to drive innovation in cancer research. Fundamental knowledge about the biology of cancer has burgeoned, but the translation of basic science discoveries to clinical advancements can be slow and inefficient; cancer engineering tools can significantly accelerate this process and a well-trained population of basic scientists is crucial to the success of this endeavor. The 30 faculty preceptors chosen for this T32 CETP possess a broad range of expertise and are leaders in their respective fields. They are well-funded and have independent R01 (cancer-related) or R01-like research support. The CETP will benefit considerably from the robust curriculum and training structure offered by the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Science’s PhD program in Cancer Engineering, a first-of-its-kind degree program established in 2023. To ensure that the predoctoral trainees from GSK supported by this program are prepared for independent careers and ultimately equipped to become leaders in the emerging field of cancer engineering, they will receive immersive laboratory training and mentorship within a culture of support and engagement. Furthermore, trainees will be informed about expected achievements during the five-year program and their progress will be continuously evaluated and benchmarked. An internal advisory committee, external advisory committee, executive committee, and training committee will provide guidance and oversight of the CETP.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $228,810 )
2026	2026	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Research Manpower	003	6	8/6/2026	COMPETING CONTINUATION	$228,810
2026	2025	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Research Manpower	001	5	6/5/2026	NON-COMPETING CONTINUATION	$0
2026	2025	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Research Manpower	002	5	8/5/2026	NON-COMPETING CONTINUATION	$0
2026	2025	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Research Manpower	000	5	12/2/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $228,810

Issue Date FY: 2025 ( Subtotal = $470,375 )
2025	2025	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Research Manpower	000	5	7/16/2025	NON-COMPETING CONTINUATION	$470,375
														Subtotal = $470,375

Issue Date FY: 2024 ( Subtotal = $401,161 )
2024	2024	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Research Manpower	000	4	8/1/2024	NON-COMPETING CONTINUATION	$401,161
														Subtotal = $401,161

Issue Date FY: 2023 ( Subtotal = $203,906 )
2023	2023	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVENUE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Research Manpower	000	3	8/16/2023	NON-COMPETING CONTINUATION	$203,906
														Subtotal = $203,906

Issue Date FY: 2022 ( Subtotal = $432,412 )
2022	2022	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Research Manpower	000	2	7/29/2022	NON-COMPETING CONTINUATION	$432,412
														Subtotal = $432,412

Issue Date FY: 2021 ( Subtotal = $411,511 )
2021	2021	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Research Manpower	000	1	8/19/2021	NEW	$411,511
														Subtotal = $411,511

Grand Total All Awards = $2,148,175

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cancer Engineering Training Program

Award Number: T32CA254875

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 08/19/2021

PERIOD OF PERFORMANCE END DATE: 08/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer